The global dry mouth relief market was valued at USD 2.48 billion in 2022 and is expected to grow at a CAGR of 6.3% during the forecast period.
The rising adoption of radiotherapy and chemotherapy for cancer treatment and increasing use of prescribed medications all over the world along with the rising incidences of dry mouth and various associated diseases like Sjogren’s syndrome, are among the leading factors driving the global market growth. In addition, the surge in the need and demand for sugar-free chewing gums, saliva substitute gels, lozenges, and mouthwashes and emphasis on maintain good oral hygiene that led to the adoption of dry mouth products which promotes overall oral health and relieve symptoms as well, are further anticipated to boost market growth over the years.
To Understand More About this Research: Request a Free Sample Report
Oral sprays are widely used or utilized for dry mouth relied treatment in an effective manner due to its ability to provide immediate and quick relief from various dry mouth symptoms and are gaining huge traction because of their portability and easy to use, as they come in compact bottles that can be easily carried in a purse or even in a pocket allowing users to get instant relief whenever needs.
For Specific Research Requirements: Request for Customized Report
However, lack of awareness among individuals about the potential impact and condition of their health and available treatment options and high-cost associated with dry mouth relief products that could deter price-sensitive consumers, are likely to hamper global market growth.
Growth Drivers
There has been substantial increase in the prevalence of various chronic disorders including diabetes, HIV/AIDS, Parkinson’s diseases, autoimmune disease, and Sjogren’s syndrome, among others which significant results in dry mouth conditions and leading to greater demand and need for dry mouth relief products, are the factors positively influencing the global dry mouth relief market growth in the recent years.
The market is primarily segmented based on product type, drug type, distribution channel, and region.
By Product Type |
By Drug Type |
By Distribution Channel |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
The mouthwash segment accounted for the largest market share. The growth of the segment market is highly attributed to widespread use by individuals because of the ability to provide immediate relief from dry mouth symptoms through moistening the oral cavity and easy availability of different types of mouthwash formulations including fluoride-enriched, natural, and alcohol-free options.
The spray segment is projected to grow at highest growth rate during the course of study period, mainly due to their rising popularity among individuals as they are easy to carry and use on the go and offers a highly convenient way to relieve dry mouths symptoms very quickly as compared to other options available in the market.
The prescribed segment held the majority market share in terms of revenue in 2022, which is majorly driven by large number of patients visit to hospitals and clinics were healthcare professionals prescribe treatments and medications for dry mouth to patients undergoing several certain dental procedures including root canal therapy. In addition, various healthcare professionals worldwide are increasingly focused on personalized medicine that tailor to dry mouth relief prescriptions to each patient's specific needs and underlying causes, which in turn, influencing the segment market growth.
The over-the-counter segment is expected to register highest growth rate over the forecast period, on account of increasing demand for over-the-counter drugs for dry mouth like saliva substitute, lozenges, toothpastes, and mouthwashes, among others because of their cost-effectiveness and easier availability compared to prescribed drugs.
E-commerce channels segment is expected to witness highest growth
The e-commerce channels segment is expected to witness highest growth during the forecast period, that is mainly attributed to rapid emergence of various healthcare pharmacies across the globe offering wide range of benefits and advantageous features including higher convenience, wide product selection from different brands, complete product information and reviews, easy accessibility, and convenient payment methods, and many others. Also, the growing proliferation of smartphones and mobile apps that have made it even easier for consumers to shop for dry mouth relief products, contributing to the market growth.
The North America region dominated the global market. The regional market growth is highly attributable to growing prevalence of xerostomia and various associated diseases and rapid increase in region’s geriatric population who are more prone to such kind of health issues. Additionally, the growing people interest in natural and holistic remedies that led to the development of dry mouth relief products with organic and natural ingredients, are further likely to gain traction among consumers seeking for alternative and chemical-free options.
The Asia Pacific will grow at rapid pace, owing to region’s rapid rate of urbanization and industrialization that led to greater consumption of processed food & beverages that could contribute to dry mouth and increasing disposable income of middle-class population in the region that makes them able to invest in products enhancing their quality of life including dry mouth relief.
The dry mouth relief market is highly fragmented in nature with the presence of several regional or global market players. Key market players are heavily investing in R&D activities to develop innovative products with long-lasting effects, advanced formulations, and inclusion of organic ingredients, that makes them competitive in the market.
Some of the major players operating in the global market include:
Report Attributes |
Details |
Market size value in 2023 |
USD 2.63 billion |
Revenue forecast in 2032 |
USD 4.58 billion |
CAGR |
6.3% from 2023 – 2032 |
Base year |
2022 |
Historical data |
2019 – 2021 |
Forecast period |
2023 – 2032 |
Quantitative units |
Revenue in USD billion and CAGR from 2023 to 2032 |
Segments covered |
By Product Type, By Drug Type, By Distribution Channel, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |